Catostylus mosaicus an autoimmune stimulant

Summary

unknown

Program

New and Emerging Animal Industries

Research Organisation

Prindel

Objective Summary

Finalise project QUT8A . Investigate the potential commercial development of therapeutic products from Catostylus mosaicus . Establish handling and processing procedures . Identify the class(es) of active components . Determine degree of activity (o r range of activity through bioassay) . Gather sufficient data to make Go/No Go decisions for commercial development

Project Code

PRJ-000835

Project Stage

Closed

Project Start Date

Monday, April 16, 2007

Project Completion Date

Friday, May 30, 2008

Journal Articles From Project

Not Available

National Priority

Frontier technologies for building and transforming Australian industries

National Priority

Advanced Technology

National Priority

NAP-Provide new and developing animal industries with regular and up-to-date market assessments

Contact

Related publications

08.07.09

The Blue Jellyfish– a promising autoimmune stimulant